股票行情快报：迈得医疗（688310）2月26日主力资金净买入223.90万元

Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Maide Medical (688310), indicating a slight decline in stock price and mixed financial results for the third quarter of 2025 [1][2]. Group 2 - As of February 26, 2026, Maide Medical's stock closed at 17.7 yuan, down 0.73%, with a turnover rate of 1.26% and a trading volume of 21,000 hands, resulting in a transaction amount of 37.23 million yuan [1]. - The net inflow of main funds on February 26 was 2.239 million yuan, accounting for 6.01% of the total transaction amount, while retail investors experienced a net outflow of 270,200 yuan, representing 0.73% of the total [1]. Group 3 - For the first three quarters of 2025, Maide Medical reported a main revenue of 225 million yuan, a year-on-year increase of 2.31%, and a net profit attributable to shareholders of 8.8367 million yuan, up 15.82% year-on-year [2]. - In Q3 2025, the company achieved a single-quarter main revenue of 83.643 million yuan, reflecting a significant year-on-year increase of 54.38%, and a net profit of 2.7916 million yuan, which is a remarkable increase of 224.07% year-on-year [2]. - The company's debt ratio stands at 29.86%, with an investment income of 167,600 yuan and financial expenses of -523,600 yuan, while the gross profit margin is reported at 40.19% [2]. Group 4 - Maide Medical specializes in the research, production, sales, and service of medical consumables and intelligent equipment, effectively integrating technology in medical device processes, automation, and software to create unique product and service advantages [2].